Details

Last Funding Type

Series C

Last Funding Money Raised

$30M

Industries

Biotechnology,Health Care,Life Science,Medical,Therapeutics

Founded date

Jan 1, 2016

Number Of Employee

51 - 100

Operating Status

Active

Legal Name

Carisma Therapeutics, Inc.

Also Known As

Carisma,CARMA Therapeutics

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors. Its cell therapies apply powerful chimeric antigen receptor technology and adoptive cell transfer in cancer therapy and to macrophages that infiltrate the solid tumor micro-environment that enables solid tumor patients to receive strong cellular immunotherapy and cancer treatments. The company's technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy for the treatment of human disease.

Founded in 2016 by Michael Klichinsky and Saar Gill, Carisma Therapeutics is headquartered in Philadelphia, Pennsylvania.